$2.7T
Total marketcap
$93.14B
Total volume
BTC 49.54%     ETH 16.98%
Dominance

Amphastar Pharmaceuticals AMPH Stock

41.98 USD {{ price }} -2.970411% {{change_pct}}%
Exchange
NasdaqGS
Market Cap
2.05B USD
LOW - HIGH [24H]
41.83 - 43.49 USD
VOLUME [24H]
360.39K USD
{{ volume }}
P/E Ratio
14.88
Earnings per share
2.82 USD

Amphastar Pharmaceuticals Price Chart

Amphastar Pharmaceuticals AMPH Financial and Trading Overview

Amphastar Pharmaceuticals stock price 41.98 USD
Previous Close 47.94 USD
Open 48.43 USD
Bid 0 USD x 1100
Ask 0 USD x 3100
Day's Range 48.43 - 52.82 USD
52 Week Range 26.76 - 52.85 USD
Volume 1.06M USD
Avg. Volume 415.91K USD
Market Cap 2.52B USD
Beta (5Y Monthly) 0.76514
PE Ratio (TTM) 28.540983
EPS (TTM) 2.82 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 50.5 USD

AMPH Valuation Measures

Enterprise Value 2.18B USD
Trailing P/E 28.540983
Forward P/E 18.390846
PEG Ratio (5 yr expected) 0.77
Price/Sales (ttm) 4.861457
Price/Book (mrq) 4.5872126
Enterprise Value/Revenue 4.209
Enterprise Value/EBITDA 15.046

Trading Information

Amphastar Pharmaceuticals Stock Price History

Beta (5Y Monthly) 0.76514
52-Week Change 65.70%
S&P500 52-Week Change 20.43%
52 Week High 52.85 USD
52 Week Low 26.76 USD
50-Day Moving Average 42.17 USD
200-Day Moving Average 33.54 USD

AMPH Share Statistics

Avg. Volume (3 month) 415.91K USD
Avg. Daily Volume (10-Days) 498.11K USD
Shares Outstanding 48.27M
Float 37.67M
Short Ratio 4.74
% Held by Insiders 22.04%
% Held by Institutions 62.57%
Shares Short 1.88M
Short % of Float 6.14%
Short % of Shares Outstanding 3.89%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 17.96%
Operating Margin (ttm) 23.00%
Gross Margin 51.45%
EBITDA Margin 27.97%

Management Effectiveness

Return on Assets (ttm) 10.00%
Return on Equity (ttm) 18.12%

Income Statement

Revenue (ttm) 518.64M USD
Revenue Per Share (ttm) 10.69 USD
Quarterly Revenue Growth (yoy) 16.30%
Gross Profit (ttm) 248.86M USD
EBITDA 145.08M USD
Net Income Avi to Common (ttm) 93.17M USD
Diluted EPS (ttm) 1.83
Quarterly Earnings Growth (yoy) 7.29%

Balance Sheet

Total Cash (mrq) 192.89M USD
Total Cash Per Share (mrq) 4 USD
Total Debt (mrq) 102.03M USD
Total Debt/Equity (mrq) 18.6 USD
Current Ratio (mrq) 3.859
Book Value Per Share (mrq) 11.386

Cash Flow Statement

Operating Cash Flow (ttm) 78.8M USD
Levered Free Cash Flow (ttm) 48.49M USD

Profile of Amphastar Pharmaceuticals

Country United States
State CA
City Rancho Cucamonga
Address 11570 6th Street
ZIP 91730
Phone 909 980 9484
Website https://www.amphastar.com
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees 1615

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and Active Pharmaceutical Ingredient (API). It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and Lorazepam injection for surgery and medical procedures. In addition, it offers Neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; Isoproterenol hydrochloride injection for mild or transient episodes of heart block; Ganirelix Acetate injection for the inhibition of premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation; and Vasopressin to increase blood pressure in adults with vasodilatory shock. Further, the company distributes recombinant human insulin APIs and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.

Q&A For Amphastar Pharmaceuticals Stock

What is a current AMPH stock price?

Amphastar Pharmaceuticals AMPH stock price today per share is 41.98 USD.

How to purchase Amphastar Pharmaceuticals stock?

You can buy AMPH shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Amphastar Pharmaceuticals?

The stock symbol or ticker of Amphastar Pharmaceuticals is AMPH.

Which industry does the Amphastar Pharmaceuticals company belong to?

The Amphastar Pharmaceuticals industry is Drug Manufacturers-Specialty & Generic.

How many shares does Amphastar Pharmaceuticals have in circulation?

The max supply of Amphastar Pharmaceuticals shares is 48.9M.

What is Amphastar Pharmaceuticals Price to Earnings Ratio (PE Ratio)?

Amphastar Pharmaceuticals PE Ratio is 14.88475100 now.

What was Amphastar Pharmaceuticals earnings per share over the trailing 12 months (TTM)?

Amphastar Pharmaceuticals EPS is 2.82 USD over the trailing 12 months.

Which sector does the Amphastar Pharmaceuticals company belong to?

The Amphastar Pharmaceuticals sector is Healthcare.

Amphastar Pharmaceuticals AMPH included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 17019.88 USD
+0.59
5.94B USD 16917.51 USD 17032.66 USD 5.94B USD
NASDAQ Biotechnology Total Retu XNBI 4689.54 USD
-1.28
4659.38 USD 4767.34 USD
Nasdaq US 700 Small Cap Index NQUS700SC 2122.88 USD
-0.3
2114.43 USD 2144.96 USD
Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG 2625.41 USD
-0.59
2616.24 USD 2651.64 USD
NASDAQ Biotechnology NBI 4363.67 USD
-1.28
4335.6 USD 4436.05 USD
NASDAQ HealthCare IXHC 978.74 USD
-1.03
973.64 USD 990.74 USD
NASDAQ Composite Total Return I XCMP 20705.72 USD
+0.59
20581.18 USD 20721.26 USD
NASDAQ Global Select Market Com NQGS 8293.85 USD
+0.61
8244.01 USD 8300.49 USD
Stlmt ID NASDAQ Biotechnology NBX 4604.4 USD
-2.98
4555.41 USD 4917.8 USD